SlideShare una empresa de Scribd logo
1 de 1
Descargar para leer sin conexión
1
VALIDATION OF RECOMBINANT PROTEIN-BASED ELISA FOR DETECTION OF
ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS TYPE-O
Eun-Jin Choi1, YuJin Han1, Jieun Ryu2, Jungho Kim2, JiHyun Lee1, Hyun Mi Pyo1, WonSeok Shin1, DoHeon Gwon1, Jae Myung Kim1, Mi-Young Park1
1 Foot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon, Gyeongsang buk-Do, Republic of Korea
2 BIONOTE Inc., 34, Samsung1ro 4-gil, Hwaseong-si, Gyeonggi-do, 18449, Republic of Korea
INTRODUCTION
Serological tests for detecting antibodies to structural proteins (SP) of Foot-and-
mouth disease virus (FMDV) are required to support assessment of vaccination
effectiveness and contribute to estimate the population immunity level for post-
vaccination monitoring. Although virus neutralization test (VNT) is prescribed in the
OIE-Manual as the golden standard method for determining SP antibodies to FMDV,
there may be disadvantages in terms of ease of use (high-level biocontainment
facilities, trained personnel, time-consuming, labor etc.) for massive screening
samples. Therefore, we have developed a new recombinant protein-based solid-
phase competitive ELISA (r-SPCE) with monoclonal antibody (Mab) for detection of
antibodies to FMDV type-O. This study describes the validation process in cattle and
pigs for this kit.
MATERIALS & METHODS
The r-SPCE kit was validated with field sera collected from either vaccinated or non-
vaccinated from non-infected cattle and pig farms, international reference sera
obtained from WRLFMD, Pirbright and sera from experimentally challenged animals.
RESULTS
The overall diagnostic specificity of 99.9% with a threshold of 50% inhibition was
identified by analyzing 1,070 cattle and 730 pigs from FMD-free and non-vaccinated
country (Canada, USA). Diagnostic sensitivity of 95.2% was estimated using 475
known positive animal sera. International reference sera were correctly detected. A
high level of serotype-specificity was demonstrated testing IAEA/FAO standard sera
strongly positive against other FMDV serotypes. Also, the coefficient of variation (CV)
obtained for evaluating reproducibility and repeatability estimated ≤1 0 %,
demonstrating the excellent stability of the r-SPCE.
Species No. of sample Specificity, % (No. of positives)
Bovine 1,070 99.0 (1)
Swine 1,170 100 (0)
Total 2,240 100% (1)
Table 1. Determination of cut-off (threshold) values
Table 4. Comparative evaluation of FMDV type-O ELISAs with VNT
Table 2. Result obtained with IAEA/FAO FMDV reference sera
Serotype Virus strain OD PI Result
O O1 Manisa 0.241 86.9 Pos.
A A 24 Cruzeiro 1.138 38.3 Neg.
Asia 1 Asia 1 Shamir 0.942 38.9 Neg.
SAT 1 SAT 1 1.273 30.9 Neg.
SAT 2 SAT 2 1.214 34.1 Neg.
SAT 3 SAT 3 1.594 13.5 Neg.
DISCUSSION
Establishing fully validated and reproducible methods for serological assessment of
detecting vaccine-induced antibodies needs considerable effort, particularly if a
various of vaccine and field strains are involved as in the case of Korea. The
recombinant protein-based SPCE developed for the detection of antibodies to
FMDV type-O demonstrated high specificity and sensitivity. In addition, this assay
offers advantages in terms of repeatability and broader cross-specificity, but also is
easy-to use and applicable to multiple species.
REFERENCES
1.Paiba GA, et al. J Virol Methods. 2004: 115(2):145-158.
2.Chénard G, et al. J Virol Methods. 2003: 107(1):89-98.
3.Kang Y, et al. BMC Vet. Research. 2018: 14:371.
Figure 1. Principle of solid-phase competitive ELISA using recombinant
VP4231 protein of FMDV O/JC/SKR/2014 (O/SEA/Mya98). ELISA plates
were coated with recombinant vp4231 antigen trapped by purified specific Mab. Test
samples and Mab-HRP conjugate are added to the wells of ELISA plate. During incubation,
if there are antibodies against O type in the test sample, the antibodies and HRP
conjugated Mabs of O type competitively bind to the antigens on the well. If binding of
the HRPO conjugate is blocked by structural protein antibodies in test samples, the
unbound conjugate will be washed away and less or no color will be developed. The
enzyme activity will thus be directly inversely proportional to the anti-FMD SP antibodies
(serotype O) in samples. Colorimetric reading will be performed by using a
spectrophotometer at 450nm and reference wavelength at 620nm.
Table 3. Diagnostic specificity at the established cut-off
The optimal cut-off for percentage of inhibition (PI) at the dilution 1/5 was determined
using receiver operated characterstics (ROC) curves obtained by known negative and
positive sera with the VNT being the golden standard. Negative sera were originated
from 1,485 different animals in non-vaccinated and FMD-free area (Canada, USA).
Positive sera were from 475 vaccinated or infected animals, which shows positive result
in VNT (serum titers ≥1/16 were considered positive.). Fifty PI represented the
threshold that best discrimated negative and positive sera. Using this cut-off, the ELISA
scored specificity of 96.0%, sensitivity of 95.2% which resulted in the maximum
accuracy of 95.8%.
1
4
16
64
256
1024
0
10
20
30
40
50
60
70
80
90
100
110
120
DPI-0 DPI-3 DPI-6 DPI-10 DPI-17 DPI-24 DPI-31
VNTTITER
PIVALUE(%)
BIONOTE Prionics VNT
Figure 4. Comparison of FMDV-O r-SPCE and VNT using sera from cattle
infected with FMDV O/AD/SKR/2010. Samples from 5 cattles were collected
daily up to 10 days post infection (DPI), and then at 7 days intervals after 10 dpi. At 6
dpi all serum samples were positive for antibodies to FMDV-O, and remained positive
until the end of the experiments (31 dpi). When compared with gold standard test VNT,
same results were observed. For VNT, serum titers ≥1/16 were considered positive.
Species Status No. of
samples
Detection rate, % (Concordance, %)
VNT R-SPCE PrioCHECK
Bovine
Vaccinated 15 100 100 (100) 100
Infected 107 90.7 90.7 (100) 90.7
Sub-total 122 91.8 91.8 (100) 91.8
Swine
Vaccinated 440 74.1 82.3 (81.4) 76.6
Infected 18 88.9 88.9 (100) 100
Sub-total 458 82.5 77.5 (82.1) 75.3
Total 580 84.5 80.5 (85.9) 78.8
Figure 3. Distribution of the PI recorded from the examination of known
negative sera for cattle (n=1,070) and pigs (n=1,170).
Figure 2. ROC curve
analysis of results of
r-SPCE test. ROC analysis
of potential cutoff values for
serum samples using FMDV-
O r-SPCE kit. Calculated
values for sensitivity,
specificity and accuracy
considering VNT was set at
the threshold 50 PI.
Serum panel from the IAEA (through the Animal Production and Health sub-programme of the
Joint FAO/IAEA Division from infected cattle which includes 6 FMDV serotypes (A, O, Asia 1, SAT 1,
SAT 2 and SAT 3) was used to evaluate cross-reactivity generated by antibodies to heterologous
serotype in the FMDV-A rELISA kit. All sera were correctly identified.
FMDV-O r-SPCE test for negative sera from animals collected in FMD-free and unvaccinated
country was almost correctly identified showing only one false positive in 2,240 samples.
The sensitivity of the FMDV-O r-SPCE relative to the VNT was 80.5% (for cattle; 91.8%
and pigs; 77.5% respectively), and high agreement (concordance 85.9%) was observed
between two tests. Also, FMDV-O r-SPCE detected 82.9% SP antibodies to FMDV type-O
for clinical serum samples from domestic animals with vaccinations, exhibiting higher
sensitivity compared to 77.4% of PrioCHECK SP type-O ELISA.
No. of
samples
Cut-off (Percentage of Inhibition, PI Value)
≥ PI 30 ≥ PI 40 ≥ PI 50 ≥ PI 60 ≥ PI 70
Specificity, % 1,485 92.3 95.0 96.0 96.8 97.9
Sensitivity, % 475 98.7 97.5 95.2 90.3 81.5
Accuracy, % 1,960 93.9 95.6 95.8 95.3 93.9

Más contenido relacionado

La actualidad más candente

ENHANCED COMPLETE GENOME SEQUENCING OF FOOT-AND-MOUTH DISEASE VIRUS USING PRO...
ENHANCED COMPLETE GENOME SEQUENCING OF FOOT-AND-MOUTH DISEASE VIRUS USING PRO...ENHANCED COMPLETE GENOME SEQUENCING OF FOOT-AND-MOUTH DISEASE VIRUS USING PRO...
ENHANCED COMPLETE GENOME SEQUENCING OF FOOT-AND-MOUTH DISEASE VIRUS USING PRO...EuFMD
 
ENHANCED DIAGNOSIS EFFICACY OF A NEWLY DEVELOPLED ELISA KIT FOR FMDV IN POOL ...
ENHANCED DIAGNOSIS EFFICACY OF A NEWLY DEVELOPLED ELISA KIT FOR FMDV IN POOL ...ENHANCED DIAGNOSIS EFFICACY OF A NEWLY DEVELOPLED ELISA KIT FOR FMDV IN POOL ...
ENHANCED DIAGNOSIS EFFICACY OF A NEWLY DEVELOPLED ELISA KIT FOR FMDV IN POOL ...EuFMD
 
COMPLEX CIRCULATION OF FOOT-AND-MOUTH DISEASE VIRUS IN CATTLE IN NIGERIA
COMPLEX CIRCULATION OF FOOT-AND-MOUTH DISEASE VIRUS IN CATTLE IN NIGERIA COMPLEX CIRCULATION OF FOOT-AND-MOUTH DISEASE VIRUS IN CATTLE IN NIGERIA
COMPLEX CIRCULATION OF FOOT-AND-MOUTH DISEASE VIRUS IN CATTLE IN NIGERIA EuFMD
 
GENETIC ANALYSIS OF THE 2013/14 SAT2 FOOT-AND-MOUTH DISEASE (FMD) OUTBREAK IN...
GENETIC ANALYSIS OF THE 2013/14 SAT2 FOOT-AND-MOUTH DISEASE (FMD) OUTBREAK IN...GENETIC ANALYSIS OF THE 2013/14 SAT2 FOOT-AND-MOUTH DISEASE (FMD) OUTBREAK IN...
GENETIC ANALYSIS OF THE 2013/14 SAT2 FOOT-AND-MOUTH DISEASE (FMD) OUTBREAK IN...EuFMD
 
CROI2010Marlowe(4) FINAL
CROI2010Marlowe(4) FINALCROI2010Marlowe(4) FINAL
CROI2010Marlowe(4) FINALRobert Bruce
 
DEVELOPMENT OF A NEW EXPERT-CURATED FOOT-AND-MOUTH DISEASE VIRUS NUCLEOTIDE S...
DEVELOPMENT OF A NEW EXPERT-CURATED FOOT-AND-MOUTH DISEASE VIRUS NUCLEOTIDE S...DEVELOPMENT OF A NEW EXPERT-CURATED FOOT-AND-MOUTH DISEASE VIRUS NUCLEOTIDE S...
DEVELOPMENT OF A NEW EXPERT-CURATED FOOT-AND-MOUTH DISEASE VIRUS NUCLEOTIDE S...EuFMD
 
DIAGNOSTIC PERFORMANCE OF FOOT-AND-MOUTH DISEASE VIRUS DETECTION AND SEROTYPI...
DIAGNOSTIC PERFORMANCE OF FOOT-AND-MOUTH DISEASE VIRUS DETECTION AND SEROTYPI...DIAGNOSTIC PERFORMANCE OF FOOT-AND-MOUTH DISEASE VIRUS DETECTION AND SEROTYPI...
DIAGNOSTIC PERFORMANCE OF FOOT-AND-MOUTH DISEASE VIRUS DETECTION AND SEROTYPI...EuFMD
 
Poster: READY-TO-USE KITS FOR DETECTION OF ANTIBODY TO FMDV SEROTYPES O, A, ASIA
Poster: READY-TO-USE KITS FOR DETECTION OF ANTIBODY TO FMDV SEROTYPES O, A, ASIAPoster: READY-TO-USE KITS FOR DETECTION OF ANTIBODY TO FMDV SEROTYPES O, A, ASIA
Poster: READY-TO-USE KITS FOR DETECTION OF ANTIBODY TO FMDV SEROTYPES O, A, ASIAFAO
 
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...dewisetiyana52
 
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...EuFMD
 
Customizable pcr microplate array for differential identification of multiple...
Customizable pcr microplate array for differential identification of multiple...Customizable pcr microplate array for differential identification of multiple...
Customizable pcr microplate array for differential identification of multiple...Tiensae Teshome
 
McGowan Katherine In vivo bioluminescence imaging can be used to monitor vari...
McGowan Katherine In vivo bioluminescence imaging can be used to monitor vari...McGowan Katherine In vivo bioluminescence imaging can be used to monitor vari...
McGowan Katherine In vivo bioluminescence imaging can be used to monitor vari...Katherine McGowan
 
Candidemia in HIV-positive patients in Dschang District Hospital (West Region...
Candidemia in HIV-positive patients in Dschang District Hospital (West Region...Candidemia in HIV-positive patients in Dschang District Hospital (West Region...
Candidemia in HIV-positive patients in Dschang District Hospital (West Region...Claude Nangwat
 
OS20 - Proven performance for FMDV NSP antibody detection with the ID Screen®...
OS20 - Proven performance for FMDV NSP antibody detection with the ID Screen®...OS20 - Proven performance for FMDV NSP antibody detection with the ID Screen®...
OS20 - Proven performance for FMDV NSP antibody detection with the ID Screen®...EuFMD
 
Izmir rust final final
Izmir rust final finalIzmir rust final final
Izmir rust final finalICARDA
 
DIAGNOSTIC ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
DIAGNOSTIC  ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCKDIAGNOSTIC  ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
DIAGNOSTIC ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCKrinkusarawade
 
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...Rafael Monleon
 
Presentation 6: Vibrio parahaemolyticus: genome plasticity, mobile genetic el...
Presentation 6: Vibrio parahaemolyticus: genome plasticity, mobile genetic el...Presentation 6: Vibrio parahaemolyticus: genome plasticity, mobile genetic el...
Presentation 6: Vibrio parahaemolyticus: genome plasticity, mobile genetic el...ExternalEvents
 
Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis is...
Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis is...Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis is...
Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis is...Intissar Guedda
 
Biological properties of African swine fever virus Odintsovo 02/14 isolate an...
Biological properties of African swine fever virus Odintsovo 02/14 isolate an...Biological properties of African swine fever virus Odintsovo 02/14 isolate an...
Biological properties of African swine fever virus Odintsovo 02/14 isolate an...Agriculture Journal IJOEAR
 

La actualidad más candente (20)

ENHANCED COMPLETE GENOME SEQUENCING OF FOOT-AND-MOUTH DISEASE VIRUS USING PRO...
ENHANCED COMPLETE GENOME SEQUENCING OF FOOT-AND-MOUTH DISEASE VIRUS USING PRO...ENHANCED COMPLETE GENOME SEQUENCING OF FOOT-AND-MOUTH DISEASE VIRUS USING PRO...
ENHANCED COMPLETE GENOME SEQUENCING OF FOOT-AND-MOUTH DISEASE VIRUS USING PRO...
 
ENHANCED DIAGNOSIS EFFICACY OF A NEWLY DEVELOPLED ELISA KIT FOR FMDV IN POOL ...
ENHANCED DIAGNOSIS EFFICACY OF A NEWLY DEVELOPLED ELISA KIT FOR FMDV IN POOL ...ENHANCED DIAGNOSIS EFFICACY OF A NEWLY DEVELOPLED ELISA KIT FOR FMDV IN POOL ...
ENHANCED DIAGNOSIS EFFICACY OF A NEWLY DEVELOPLED ELISA KIT FOR FMDV IN POOL ...
 
COMPLEX CIRCULATION OF FOOT-AND-MOUTH DISEASE VIRUS IN CATTLE IN NIGERIA
COMPLEX CIRCULATION OF FOOT-AND-MOUTH DISEASE VIRUS IN CATTLE IN NIGERIA COMPLEX CIRCULATION OF FOOT-AND-MOUTH DISEASE VIRUS IN CATTLE IN NIGERIA
COMPLEX CIRCULATION OF FOOT-AND-MOUTH DISEASE VIRUS IN CATTLE IN NIGERIA
 
GENETIC ANALYSIS OF THE 2013/14 SAT2 FOOT-AND-MOUTH DISEASE (FMD) OUTBREAK IN...
GENETIC ANALYSIS OF THE 2013/14 SAT2 FOOT-AND-MOUTH DISEASE (FMD) OUTBREAK IN...GENETIC ANALYSIS OF THE 2013/14 SAT2 FOOT-AND-MOUTH DISEASE (FMD) OUTBREAK IN...
GENETIC ANALYSIS OF THE 2013/14 SAT2 FOOT-AND-MOUTH DISEASE (FMD) OUTBREAK IN...
 
CROI2010Marlowe(4) FINAL
CROI2010Marlowe(4) FINALCROI2010Marlowe(4) FINAL
CROI2010Marlowe(4) FINAL
 
DEVELOPMENT OF A NEW EXPERT-CURATED FOOT-AND-MOUTH DISEASE VIRUS NUCLEOTIDE S...
DEVELOPMENT OF A NEW EXPERT-CURATED FOOT-AND-MOUTH DISEASE VIRUS NUCLEOTIDE S...DEVELOPMENT OF A NEW EXPERT-CURATED FOOT-AND-MOUTH DISEASE VIRUS NUCLEOTIDE S...
DEVELOPMENT OF A NEW EXPERT-CURATED FOOT-AND-MOUTH DISEASE VIRUS NUCLEOTIDE S...
 
DIAGNOSTIC PERFORMANCE OF FOOT-AND-MOUTH DISEASE VIRUS DETECTION AND SEROTYPI...
DIAGNOSTIC PERFORMANCE OF FOOT-AND-MOUTH DISEASE VIRUS DETECTION AND SEROTYPI...DIAGNOSTIC PERFORMANCE OF FOOT-AND-MOUTH DISEASE VIRUS DETECTION AND SEROTYPI...
DIAGNOSTIC PERFORMANCE OF FOOT-AND-MOUTH DISEASE VIRUS DETECTION AND SEROTYPI...
 
Poster: READY-TO-USE KITS FOR DETECTION OF ANTIBODY TO FMDV SEROTYPES O, A, ASIA
Poster: READY-TO-USE KITS FOR DETECTION OF ANTIBODY TO FMDV SEROTYPES O, A, ASIAPoster: READY-TO-USE KITS FOR DETECTION OF ANTIBODY TO FMDV SEROTYPES O, A, ASIA
Poster: READY-TO-USE KITS FOR DETECTION OF ANTIBODY TO FMDV SEROTYPES O, A, ASIA
 
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
 
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
 
Customizable pcr microplate array for differential identification of multiple...
Customizable pcr microplate array for differential identification of multiple...Customizable pcr microplate array for differential identification of multiple...
Customizable pcr microplate array for differential identification of multiple...
 
McGowan Katherine In vivo bioluminescence imaging can be used to monitor vari...
McGowan Katherine In vivo bioluminescence imaging can be used to monitor vari...McGowan Katherine In vivo bioluminescence imaging can be used to monitor vari...
McGowan Katherine In vivo bioluminescence imaging can be used to monitor vari...
 
Candidemia in HIV-positive patients in Dschang District Hospital (West Region...
Candidemia in HIV-positive patients in Dschang District Hospital (West Region...Candidemia in HIV-positive patients in Dschang District Hospital (West Region...
Candidemia in HIV-positive patients in Dschang District Hospital (West Region...
 
OS20 - Proven performance for FMDV NSP antibody detection with the ID Screen®...
OS20 - Proven performance for FMDV NSP antibody detection with the ID Screen®...OS20 - Proven performance for FMDV NSP antibody detection with the ID Screen®...
OS20 - Proven performance for FMDV NSP antibody detection with the ID Screen®...
 
Izmir rust final final
Izmir rust final finalIzmir rust final final
Izmir rust final final
 
DIAGNOSTIC ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
DIAGNOSTIC  ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCKDIAGNOSTIC  ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
DIAGNOSTIC ADVANCES IN HAEMOPROTOZOAN INFECTIONS OF LIVESTOCK
 
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
Occurrence and Distribution of Transmissible Viral Proventriculitis in North ...
 
Presentation 6: Vibrio parahaemolyticus: genome plasticity, mobile genetic el...
Presentation 6: Vibrio parahaemolyticus: genome plasticity, mobile genetic el...Presentation 6: Vibrio parahaemolyticus: genome plasticity, mobile genetic el...
Presentation 6: Vibrio parahaemolyticus: genome plasticity, mobile genetic el...
 
Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis is...
Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis is...Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis is...
Phenotypic and genotypic typing of Salmonella enterica serovar Enteritidis is...
 
Biological properties of African swine fever virus Odintsovo 02/14 isolate an...
Biological properties of African swine fever virus Odintsovo 02/14 isolate an...Biological properties of African swine fever virus Odintsovo 02/14 isolate an...
Biological properties of African swine fever virus Odintsovo 02/14 isolate an...
 

Similar a VALIDATION OF RECOMBINANT PROTEIN-BASED ELISA FOR DETECTION OF ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS TYPE-O

DEVELOPMENT OF SOLID-PHASE COMPETITION ELISA FOR DETECTION OF TYPE-A FOOT AND...
DEVELOPMENT OF SOLID-PHASE COMPETITION ELISA FOR DETECTION OF TYPE-A FOOT AND...DEVELOPMENT OF SOLID-PHASE COMPETITION ELISA FOR DETECTION OF TYPE-A FOOT AND...
DEVELOPMENT OF SOLID-PHASE COMPETITION ELISA FOR DETECTION OF TYPE-A FOOT AND...EuFMD
 
COMPARISON OF DIAGNOSTIC PERFORMANCES OF THREE COMMERCIAL ELISA KITS FOR DETE...
COMPARISON OF DIAGNOSTIC PERFORMANCES OF THREE COMMERCIAL ELISA KITS FOR DETE...COMPARISON OF DIAGNOSTIC PERFORMANCES OF THREE COMMERCIAL ELISA KITS FOR DETE...
COMPARISON OF DIAGNOSTIC PERFORMANCES OF THREE COMMERCIAL ELISA KITS FOR DETE...EuFMD
 
COMPARISON OF ANTIGEN DETECTION METHODS OF PESTE DES PETITS RUMINANTS VIRUS I...
COMPARISON OF ANTIGEN DETECTION METHODS OF PESTE DES PETITS RUMINANTS VIRUS I...COMPARISON OF ANTIGEN DETECTION METHODS OF PESTE DES PETITS RUMINANTS VIRUS I...
COMPARISON OF ANTIGEN DETECTION METHODS OF PESTE DES PETITS RUMINANTS VIRUS I...ZULKIFAL HUSSAIN
 
A PAN-SEROTYPE SOLID PHASE BLOCKING ELISA PROTOTYPE FOR DETECTION OF STRUCTUR...
A PAN-SEROTYPE SOLID PHASE BLOCKING ELISA PROTOTYPE FOR DETECTION OF STRUCTUR...A PAN-SEROTYPE SOLID PHASE BLOCKING ELISA PROTOTYPE FOR DETECTION OF STRUCTUR...
A PAN-SEROTYPE SOLID PHASE BLOCKING ELISA PROTOTYPE FOR DETECTION OF STRUCTUR...EuFMD
 
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...EuFMD
 
Validation of Opsonophagocytic assay for pnemococcal vaccine
Validation of Opsonophagocytic assay for pnemococcal vaccineValidation of Opsonophagocytic assay for pnemococcal vaccine
Validation of Opsonophagocytic assay for pnemococcal vaccinekishor kulkarni
 
Poster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDVPoster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDVSergio Exopol
 
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_FinalLawrence Hwang
 
Rapid detection of Foot and Mouth Disease Non-Structural Proteins using later...
Rapid detection of Foot and Mouth Disease Non-Structural Proteins using later...Rapid detection of Foot and Mouth Disease Non-Structural Proteins using later...
Rapid detection of Foot and Mouth Disease Non-Structural Proteins using later...David Dazhia Lazarus
 
RNA Extraction of Peste Des Petits Ruminants Virus (PPRV) from Clinical Sampl...
RNA Extraction of Peste Des Petits Ruminants Virus (PPRV) from Clinical Sampl...RNA Extraction of Peste Des Petits Ruminants Virus (PPRV) from Clinical Sampl...
RNA Extraction of Peste Des Petits Ruminants Virus (PPRV) from Clinical Sampl...ZULKIFAL HUSSAIN
 
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Álvaro L. Valiñas
 
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Álvaro L. Valiñas
 
OS20 - Developing of a liquid-phase blocking ELISA based on Foot-and-Mouth di...
OS20 - Developing of a liquid-phase blocking ELISA based on Foot-and-Mouth di...OS20 - Developing of a liquid-phase blocking ELISA based on Foot-and-Mouth di...
OS20 - Developing of a liquid-phase blocking ELISA based on Foot-and-Mouth di...EuFMD
 
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...EuFMD
 
Automation in microbiology, changing concept and defeating challenges
Automation in microbiology, changing concept and defeating challengesAutomation in microbiology, changing concept and defeating challenges
Automation in microbiology, changing concept and defeating challengesAyman Allam
 
EVALUATION OF THE ANTIGENIC RELATEDNESS BETWEEN FOOT-AND-MOUTH DISEASE VACCIN...
EVALUATION OF THE ANTIGENIC RELATEDNESS BETWEEN FOOT-AND-MOUTH DISEASE VACCIN...EVALUATION OF THE ANTIGENIC RELATEDNESS BETWEEN FOOT-AND-MOUTH DISEASE VACCIN...
EVALUATION OF THE ANTIGENIC RELATEDNESS BETWEEN FOOT-AND-MOUTH DISEASE VACCIN...EuFMD
 
OS16 - 4.P1.d Effect of the Antigen Payload, Polyvalency and Re-Vaccination...
OS16 - 4.P1.d   Effect of the Antigen Payload, Polyvalency and Re-Vaccination...OS16 - 4.P1.d   Effect of the Antigen Payload, Polyvalency and Re-Vaccination...
OS16 - 4.P1.d Effect of the Antigen Payload, Polyvalency and Re-Vaccination...EuFMD
 
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...EuFMD
 
Hofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice correctedHofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice correctedCatherine A. Hofstetter
 

Similar a VALIDATION OF RECOMBINANT PROTEIN-BASED ELISA FOR DETECTION OF ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS TYPE-O (20)

DEVELOPMENT OF SOLID-PHASE COMPETITION ELISA FOR DETECTION OF TYPE-A FOOT AND...
DEVELOPMENT OF SOLID-PHASE COMPETITION ELISA FOR DETECTION OF TYPE-A FOOT AND...DEVELOPMENT OF SOLID-PHASE COMPETITION ELISA FOR DETECTION OF TYPE-A FOOT AND...
DEVELOPMENT OF SOLID-PHASE COMPETITION ELISA FOR DETECTION OF TYPE-A FOOT AND...
 
COMPARISON OF DIAGNOSTIC PERFORMANCES OF THREE COMMERCIAL ELISA KITS FOR DETE...
COMPARISON OF DIAGNOSTIC PERFORMANCES OF THREE COMMERCIAL ELISA KITS FOR DETE...COMPARISON OF DIAGNOSTIC PERFORMANCES OF THREE COMMERCIAL ELISA KITS FOR DETE...
COMPARISON OF DIAGNOSTIC PERFORMANCES OF THREE COMMERCIAL ELISA KITS FOR DETE...
 
COMPARISON OF ANTIGEN DETECTION METHODS OF PESTE DES PETITS RUMINANTS VIRUS I...
COMPARISON OF ANTIGEN DETECTION METHODS OF PESTE DES PETITS RUMINANTS VIRUS I...COMPARISON OF ANTIGEN DETECTION METHODS OF PESTE DES PETITS RUMINANTS VIRUS I...
COMPARISON OF ANTIGEN DETECTION METHODS OF PESTE DES PETITS RUMINANTS VIRUS I...
 
A PAN-SEROTYPE SOLID PHASE BLOCKING ELISA PROTOTYPE FOR DETECTION OF STRUCTUR...
A PAN-SEROTYPE SOLID PHASE BLOCKING ELISA PROTOTYPE FOR DETECTION OF STRUCTUR...A PAN-SEROTYPE SOLID PHASE BLOCKING ELISA PROTOTYPE FOR DETECTION OF STRUCTUR...
A PAN-SEROTYPE SOLID PHASE BLOCKING ELISA PROTOTYPE FOR DETECTION OF STRUCTUR...
 
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
 
Validation of Opsonophagocytic assay for pnemococcal vaccine
Validation of Opsonophagocytic assay for pnemococcal vaccineValidation of Opsonophagocytic assay for pnemococcal vaccine
Validation of Opsonophagocytic assay for pnemococcal vaccine
 
Poster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDVPoster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDV
 
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
 
Rapid detection of Foot and Mouth Disease Non-Structural Proteins using later...
Rapid detection of Foot and Mouth Disease Non-Structural Proteins using later...Rapid detection of Foot and Mouth Disease Non-Structural Proteins using later...
Rapid detection of Foot and Mouth Disease Non-Structural Proteins using later...
 
RNA Extraction of Peste Des Petits Ruminants Virus (PPRV) from Clinical Sampl...
RNA Extraction of Peste Des Petits Ruminants Virus (PPRV) from Clinical Sampl...RNA Extraction of Peste Des Petits Ruminants Virus (PPRV) from Clinical Sampl...
RNA Extraction of Peste Des Petits Ruminants Virus (PPRV) from Clinical Sampl...
 
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
 
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
Variation analysis of Swine influenza virus (SIV) H1N1 sequences in experimen...
 
OS20 - Developing of a liquid-phase blocking ELISA based on Foot-and-Mouth di...
OS20 - Developing of a liquid-phase blocking ELISA based on Foot-and-Mouth di...OS20 - Developing of a liquid-phase blocking ELISA based on Foot-and-Mouth di...
OS20 - Developing of a liquid-phase blocking ELISA based on Foot-and-Mouth di...
 
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
DEVELOPMENT OF A LIQUID-PHASE BLOCKING ELISA BASED ON FOOT-AND-MOUTH DISEASE ...
 
Automation in microbiology, changing concept and defeating challenges
Automation in microbiology, changing concept and defeating challengesAutomation in microbiology, changing concept and defeating challenges
Automation in microbiology, changing concept and defeating challenges
 
sag1
sag1sag1
sag1
 
EVALUATION OF THE ANTIGENIC RELATEDNESS BETWEEN FOOT-AND-MOUTH DISEASE VACCIN...
EVALUATION OF THE ANTIGENIC RELATEDNESS BETWEEN FOOT-AND-MOUTH DISEASE VACCIN...EVALUATION OF THE ANTIGENIC RELATEDNESS BETWEEN FOOT-AND-MOUTH DISEASE VACCIN...
EVALUATION OF THE ANTIGENIC RELATEDNESS BETWEEN FOOT-AND-MOUTH DISEASE VACCIN...
 
OS16 - 4.P1.d Effect of the Antigen Payload, Polyvalency and Re-Vaccination...
OS16 - 4.P1.d   Effect of the Antigen Payload, Polyvalency and Re-Vaccination...OS16 - 4.P1.d   Effect of the Antigen Payload, Polyvalency and Re-Vaccination...
OS16 - 4.P1.d Effect of the Antigen Payload, Polyvalency and Re-Vaccination...
 
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
EXPERIMENTAL EVALUATION OF FOOT-AND-MOUTH DISEASE O SKR VACCINE: PROTECTIVE E...
 
Hofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice correctedHofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice corrected
 

Más de EuFMD

VADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdfVADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdfEuFMD
 
Vaccine delivery and demand workshop
Vaccine delivery and demand workshopVaccine delivery and demand workshop
Vaccine delivery and demand workshopEuFMD
 
Emergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdfEmergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdfEuFMD
 
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...EuFMD
 
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...EuFMD
 
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...EuFMD
 
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...EuFMD
 
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...EuFMD
 
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...EuFMD
 
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...EuFMD
 
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...EuFMD
 
LSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in AlbaniaLSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in AlbaniaEuFMD
 
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...EuFMD
 
LSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong KongLSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong KongEuFMD
 
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...EuFMD
 
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...EuFMD
 
LSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from IndiaLSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from IndiaEuFMD
 
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...EuFMD
 
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...EuFMD
 
LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin diseaseLSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin diseaseEuFMD
 

Más de EuFMD (20)

VADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdfVADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdf
 
Vaccine delivery and demand workshop
Vaccine delivery and demand workshopVaccine delivery and demand workshop
Vaccine delivery and demand workshop
 
Emergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdfEmergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdf
 
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
 
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
 
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
 
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
 
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
 
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
 
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
 
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
 
LSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in AlbaniaLSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in Albania
 
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
 
LSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong KongLSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong Kong
 
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
 
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
 
LSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from IndiaLSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from India
 
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
 
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
 
LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin diseaseLSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
 

Último

Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 

Último (20)

Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 

VALIDATION OF RECOMBINANT PROTEIN-BASED ELISA FOR DETECTION OF ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS TYPE-O

  • 1. 1 VALIDATION OF RECOMBINANT PROTEIN-BASED ELISA FOR DETECTION OF ANTIBODIES TO FOOT-AND-MOUTH DISEASE VIRUS TYPE-O Eun-Jin Choi1, YuJin Han1, Jieun Ryu2, Jungho Kim2, JiHyun Lee1, Hyun Mi Pyo1, WonSeok Shin1, DoHeon Gwon1, Jae Myung Kim1, Mi-Young Park1 1 Foot and Mouth Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon, Gyeongsang buk-Do, Republic of Korea 2 BIONOTE Inc., 34, Samsung1ro 4-gil, Hwaseong-si, Gyeonggi-do, 18449, Republic of Korea INTRODUCTION Serological tests for detecting antibodies to structural proteins (SP) of Foot-and- mouth disease virus (FMDV) are required to support assessment of vaccination effectiveness and contribute to estimate the population immunity level for post- vaccination monitoring. Although virus neutralization test (VNT) is prescribed in the OIE-Manual as the golden standard method for determining SP antibodies to FMDV, there may be disadvantages in terms of ease of use (high-level biocontainment facilities, trained personnel, time-consuming, labor etc.) for massive screening samples. Therefore, we have developed a new recombinant protein-based solid- phase competitive ELISA (r-SPCE) with monoclonal antibody (Mab) for detection of antibodies to FMDV type-O. This study describes the validation process in cattle and pigs for this kit. MATERIALS & METHODS The r-SPCE kit was validated with field sera collected from either vaccinated or non- vaccinated from non-infected cattle and pig farms, international reference sera obtained from WRLFMD, Pirbright and sera from experimentally challenged animals. RESULTS The overall diagnostic specificity of 99.9% with a threshold of 50% inhibition was identified by analyzing 1,070 cattle and 730 pigs from FMD-free and non-vaccinated country (Canada, USA). Diagnostic sensitivity of 95.2% was estimated using 475 known positive animal sera. International reference sera were correctly detected. A high level of serotype-specificity was demonstrated testing IAEA/FAO standard sera strongly positive against other FMDV serotypes. Also, the coefficient of variation (CV) obtained for evaluating reproducibility and repeatability estimated ≤1 0 %, demonstrating the excellent stability of the r-SPCE. Species No. of sample Specificity, % (No. of positives) Bovine 1,070 99.0 (1) Swine 1,170 100 (0) Total 2,240 100% (1) Table 1. Determination of cut-off (threshold) values Table 4. Comparative evaluation of FMDV type-O ELISAs with VNT Table 2. Result obtained with IAEA/FAO FMDV reference sera Serotype Virus strain OD PI Result O O1 Manisa 0.241 86.9 Pos. A A 24 Cruzeiro 1.138 38.3 Neg. Asia 1 Asia 1 Shamir 0.942 38.9 Neg. SAT 1 SAT 1 1.273 30.9 Neg. SAT 2 SAT 2 1.214 34.1 Neg. SAT 3 SAT 3 1.594 13.5 Neg. DISCUSSION Establishing fully validated and reproducible methods for serological assessment of detecting vaccine-induced antibodies needs considerable effort, particularly if a various of vaccine and field strains are involved as in the case of Korea. The recombinant protein-based SPCE developed for the detection of antibodies to FMDV type-O demonstrated high specificity and sensitivity. In addition, this assay offers advantages in terms of repeatability and broader cross-specificity, but also is easy-to use and applicable to multiple species. REFERENCES 1.Paiba GA, et al. J Virol Methods. 2004: 115(2):145-158. 2.Chénard G, et al. J Virol Methods. 2003: 107(1):89-98. 3.Kang Y, et al. BMC Vet. Research. 2018: 14:371. Figure 1. Principle of solid-phase competitive ELISA using recombinant VP4231 protein of FMDV O/JC/SKR/2014 (O/SEA/Mya98). ELISA plates were coated with recombinant vp4231 antigen trapped by purified specific Mab. Test samples and Mab-HRP conjugate are added to the wells of ELISA plate. During incubation, if there are antibodies against O type in the test sample, the antibodies and HRP conjugated Mabs of O type competitively bind to the antigens on the well. If binding of the HRPO conjugate is blocked by structural protein antibodies in test samples, the unbound conjugate will be washed away and less or no color will be developed. The enzyme activity will thus be directly inversely proportional to the anti-FMD SP antibodies (serotype O) in samples. Colorimetric reading will be performed by using a spectrophotometer at 450nm and reference wavelength at 620nm. Table 3. Diagnostic specificity at the established cut-off The optimal cut-off for percentage of inhibition (PI) at the dilution 1/5 was determined using receiver operated characterstics (ROC) curves obtained by known negative and positive sera with the VNT being the golden standard. Negative sera were originated from 1,485 different animals in non-vaccinated and FMD-free area (Canada, USA). Positive sera were from 475 vaccinated or infected animals, which shows positive result in VNT (serum titers ≥1/16 were considered positive.). Fifty PI represented the threshold that best discrimated negative and positive sera. Using this cut-off, the ELISA scored specificity of 96.0%, sensitivity of 95.2% which resulted in the maximum accuracy of 95.8%. 1 4 16 64 256 1024 0 10 20 30 40 50 60 70 80 90 100 110 120 DPI-0 DPI-3 DPI-6 DPI-10 DPI-17 DPI-24 DPI-31 VNTTITER PIVALUE(%) BIONOTE Prionics VNT Figure 4. Comparison of FMDV-O r-SPCE and VNT using sera from cattle infected with FMDV O/AD/SKR/2010. Samples from 5 cattles were collected daily up to 10 days post infection (DPI), and then at 7 days intervals after 10 dpi. At 6 dpi all serum samples were positive for antibodies to FMDV-O, and remained positive until the end of the experiments (31 dpi). When compared with gold standard test VNT, same results were observed. For VNT, serum titers ≥1/16 were considered positive. Species Status No. of samples Detection rate, % (Concordance, %) VNT R-SPCE PrioCHECK Bovine Vaccinated 15 100 100 (100) 100 Infected 107 90.7 90.7 (100) 90.7 Sub-total 122 91.8 91.8 (100) 91.8 Swine Vaccinated 440 74.1 82.3 (81.4) 76.6 Infected 18 88.9 88.9 (100) 100 Sub-total 458 82.5 77.5 (82.1) 75.3 Total 580 84.5 80.5 (85.9) 78.8 Figure 3. Distribution of the PI recorded from the examination of known negative sera for cattle (n=1,070) and pigs (n=1,170). Figure 2. ROC curve analysis of results of r-SPCE test. ROC analysis of potential cutoff values for serum samples using FMDV- O r-SPCE kit. Calculated values for sensitivity, specificity and accuracy considering VNT was set at the threshold 50 PI. Serum panel from the IAEA (through the Animal Production and Health sub-programme of the Joint FAO/IAEA Division from infected cattle which includes 6 FMDV serotypes (A, O, Asia 1, SAT 1, SAT 2 and SAT 3) was used to evaluate cross-reactivity generated by antibodies to heterologous serotype in the FMDV-A rELISA kit. All sera were correctly identified. FMDV-O r-SPCE test for negative sera from animals collected in FMD-free and unvaccinated country was almost correctly identified showing only one false positive in 2,240 samples. The sensitivity of the FMDV-O r-SPCE relative to the VNT was 80.5% (for cattle; 91.8% and pigs; 77.5% respectively), and high agreement (concordance 85.9%) was observed between two tests. Also, FMDV-O r-SPCE detected 82.9% SP antibodies to FMDV type-O for clinical serum samples from domestic animals with vaccinations, exhibiting higher sensitivity compared to 77.4% of PrioCHECK SP type-O ELISA. No. of samples Cut-off (Percentage of Inhibition, PI Value) ≥ PI 30 ≥ PI 40 ≥ PI 50 ≥ PI 60 ≥ PI 70 Specificity, % 1,485 92.3 95.0 96.0 96.8 97.9 Sensitivity, % 475 98.7 97.5 95.2 90.3 81.5 Accuracy, % 1,960 93.9 95.6 95.8 95.3 93.9